The Brazilian Health Regulatory Agency (ANVISA) has issued a technical note detailing the classification process for formulated products derived from equivalent technical products. This guidance ensures consistency in toxicological classification, particularly when complete product studies are unavailable, aligning with the standards of RDC No. 294, issued on July 29, 2019.
ANVISA's classification framework evaluates formulated products using toxicological studies or, when unavailable, by analyzing the toxicological properties of individual components. This approach ensures comprehensive health and safety assessments, adhering to Good Laboratory Practices (GLP) and the standards set by the Brazilian Ministry of Agriculture.
The classification process relies on toxicological studies that address the following health endpoints:
When multiple toxicological endpoints are considered, the most restrictive classification is applied to ensure safety.
For products lacking toxicological studies, the classification relies on the properties of individual components. This process involves:
The classification extends to critical hazards, such as:
To ensure transparency and compliance, the document specifies requirements for labeling and package inserts:
Additionally, hazard classification details must be included in the Optimized Reading Leaflet (FLORA), part of the Register of Agrochemicals.
This technical note underscores ANVISA's commitment to public health, environmental safety, and regulatory alignment. By establishing clear criteria for classifying toxicological risks, the agency ensures:
ANVISA's updated guidelines for toxicological classification offer a robust framework for ensuring the safe use, labeling, and management of formulated products. For further details, refer to the complete guidelines available (in Portuguese) here.